PCIB.OL

PCI Biotech Holding ASA [PCIB.OL] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

PCIB.OL Stock Summary

Top 10 Correlated Stocks

PCIB.OL


In the News

PCIB.OL Financial details

Company Rating
Neutral
Market Cap
73.68M
Income
-73.45M
Revenue
0
Book val./share
1.7
Cash/share
1.8
Dividend
-
Dividend %
-
Employees
14
Optionable
No
Shortable
Yes
Earnings
09 May 2023
P/E
-0.98
Forward P/E
-
PEG
-1.21
P/S
-
P/B
1.13
P/C
1.12
P/FCF
-1.15
Quick Ratio
6.97
Current Ratio
7.52
Debt / Equity
0.16
LT Debt / Equity
0.01
-
-
EPS (TTM)
-2.1
EPS next Y
-
EPS next Q
-
EPS this Y
-56.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-25.64%
-
-
-
-
SMA20
-17.07%
SMA50
-1.92%
SMA100
10.87%
Inst Own
-
Inst Trans
-
ROA
-99%
ROE
-86%
ROC
-1.13%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
39.33M
Shs Float
28.79M
-
-
-
-
Target Price
-
52W Range
1.518-5.96
52W High
-59.6%
52W Low
+102%
RSI
41.96
Rel Volume
0.03
Avg Volume
518.21K
Volume
14.67K
Perf Week
-6.91%
Perf Month
-12.55%
Perf Quarter
20.67%
Perf Half Y
1.92%
-
-
-
-
Beta
1.9412
-
-
Volatility
0.03%, 0.22%
Prev Close
-1.22%
Price
2.02
Change
6.09%

PCIB.OL Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
00000
Net income per share
-1.63-1.25-2.38-1.94-0.84
Operating cash flow per share
-1.17-1.12-2.24-2.08-0.65
Free cash flow per share
-1.17-1.12-2.24-2.08-0.65
Cash per share
1.9112.546.985.021.1
Book value per share
1.612.236.845.081.08
Tangible book value per share
1.612.236.845.081.08
Share holders equity per share
1.612.236.845.081.08
Interest debt per share
000.050.030.02
Market cap
1.03B750.52M2.86B1.04B1.46B
Enterprise value
974.85M401.89M2.6B853.76M1.35B
P/E ratio
-23.93-21.58-32.18-14.4-16.51
Price to sales ratio
00000
POCF ratio
-33.48-24.15-34.21-13.44-21.36
PFCF ratio
-33.48-24.15-34.21-13.44-21.36
P/B Ratio
24.52.2111.215.512.82
PTB ratio
24.52.2111.215.512.82
EV to sales
00000
Enterprise value over EBITDA
-22.76-11.6-29.75-12.26-15.69
EV to operating cash flow
-31.84-12.93-31.11-11.03-19.7
EV to free cash flow
-31.84-12.93-31.11-11.03-19.7
Earnings yield
-0.04-0.05-0.03-0.07-0.06
Free cash flow yield
-0.03-0.04-0.03-0.07-0.05
Debt to equity
0.40.050.110.110.19
Debt to assets
0.280.050.10.10.16
Net debt to EBITDA
1.1710.062.962.681.32
Current ratio
4.0121.0111.210.136.14
Interest coverage
0-380.5-175.5-206.85-966.62
Income quality
0.710.890.941.070.77
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
7.6618.5619.1614.874.54
ROIC
10.130.360.480.88
Return on tangible assets
-0.73-0.1-0.31-0.35-0.65
Graham Net
1.2811.936.254.490.89
Working capital
43.83M340.04M251.12M181.28M107.41M
Tangible asset value
41.84M339.95M254.83M189.24M113.79M
Net current asset value
41.82M339.94M248.55M181.25M106.13M
Invested capital
00000.02
Average receivables
00000
Average payables
1.79M1.69M5.25M6.9M4.47M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-1.02-0.1-0.35-0.38-0.78
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
00000
Net income per share
-0.57-0.8-0.62-0.39-0.29
Operating cash flow per share
-0.35-0.55-0.58-0.49-0.24
Free cash flow per share
-0.35-0.55-0.58-0.49-0.24
Cash per share
3.633.662.512.041.8
Book value per share
3.653.622.382.031.7
Tangible book value per share
3.653.622.382.031.7
Share holders equity per share
3.653.622.382.031.7
Interest debt per share
0.06-0.030.060.050.04
Market cap
636.41M437.15M162.07M150.8M64.42M
Enterprise value
502.9M323.88M70.14M76.06M-1.37M
P/E ratio
-7.43-4.36-1.76-2.57-1.51
Price to sales ratio
00000
POCF ratio
-48.43-25.24-7.51-8.3-7.29
PFCF ratio
-48.43-25.24-7.51-8.3-7.29
P/B Ratio
4.673.841.831.991.01
PTB ratio
4.673.841.831.991.01
EV to sales
00000
Enterprise value over EBITDA
-24.44-11.83-4.25-5.330.13
EV to operating cash flow
-38.27-18.7-3.25-4.190.15
EV to free cash flow
-38.27-18.7-3.25-4.190.15
Earnings yield
-0.03-0.06-0.14-0.1-0.17
Free cash flow yield
-0.02-0.04-0.13-0.12-0.14
Debt to equity
0.140.190.230.230.16
Debt to assets
0.120.160.190.190.14
Net debt to EBITDA
6.494.145.585.246.3
Current ratio
8.536.145.535.617.52
Interest coverage
-107.677.78-38.39-60.62-121.61
Income quality
0.610.690.941.240.83
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
6.868.065.744.243.31
ROIC
0.190.240.280.240.17
Return on tangible assets
-0.14-0.18-0.21-0.16-0.14
Graham Net
3.132.961.961.581.52
Working capital
129.27M107.41M88.19M75.32M62.87M
Tangible asset value
136.14M113.79M88.8M75.93M63.48M
Net current asset value
127.88M106.13M87.07M74.36M62.07M
Invested capital
0.010.020.020.020.02
Average receivables
00000
Average payables
3.09M2.92M4.08M4.91M3.87M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.16-0.22-0.26-0.19-0.17
Capex per share
00000

PCIB.OL Frequently Asked Questions

What is PCI Biotech Holding ASA stock symbol ?

PCI Biotech Holding ASA is a NO stock and trading under the symbol PCIB.OL

What is PCI Biotech Holding ASA stock quote today ?

PCI Biotech Holding ASA stock price is $2.02 today.

Is PCI Biotech Holding ASA stock public?

Yes, PCI Biotech Holding ASA is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap